Treatment of cultured human tumor cells with the chloroethylnitrosourea antitumor drug 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU) selectively induces transcription and protein synthesis of a subset of the human heat shock or stress-induced genes (HSP90 and HSP70) with little effect on other stress genes or on expression of the c-fos, c-myc, or .8-actin genes. The active component of BCNU and related compounds appears to be the isocyanate moiety that causes carbamoylation of proteins and nucleic acids. Transcriptional activation of the human HSP70 gene by BCNU is dependent on the heat shock element and correlates with the level of heat shock transcription factor and its binding to the heat shock element in vivo. Unlike activation by heat or heavy metals, BCNU-mediated activation is strongly dependent upon new protein synthesis. This suggests that BCNU-induced, isocyanate-mediated damage to newly synthesized protein(s) may be responsible for activation of the heat shock transcription factor and increased transcription of the HSP90 and HSP70 genes.
The chloroethylnitrosoureas (CENUs) are a class of antineoplastic agents used in clinical treatment of various tumors, These compounds are not biologically active in their parent state. They are chemically unstable in aqueous solution at physiological temperature and pH, undergoing spontaneous base-catalyzed decomposition to yield two bioactive species: a chloroethyldiazonium ion that alkylates and crosslinks and an isocyanate with carbamoylating activity (1) . Interaction of these reactive species with cellular macromolecules is thought to initiate the events leading to the observed antitumor activity and cellular toxicity. DNA alkylation by the chloroethyldiazonium ion may generate single-strand breaks (2) , which can subsequently react to produce DNA/DNA (2) or DNA/protein crosslinks (3) . The role of isocyanate carbamoylation to overall cytotoxicity is not clearly established. However, a secondary role due to inhibitory effects on DNA polymerase activity (4) , the repair of DNA strand breaks (5), RNA synthesis and processing (4) , and regeneration of intracellular glutathione (6) has been demonstrated. The observed antitumor efficacy is most likely due to alkylating activity since nitrosoureas such as chlorozotocin, which lack carbamoylating activity, still retain efficacy.
The cytotoxic effects of antitumor compounds might be expected to perturb cellular homeostasis and activate expression of the heat shock or stress-induced proteins (HSPs). The stress proteins are induced in response to a wide range of external stresses, including heat shock, heavy metals, amino acid analogues, oxidizing agents, and teratogens (7) (8) (9) . Given the wide range of conditions that cause the increased expression of stress proteins, we examined the effect of a broad range of antitumor drugs on cultured human cells. Although we had expected that most, if not all, cytotoxic antitumor drugs would induce stress proteins, we found that only the CENUs were potent activators ofthe human heat shock gene expression (10) . In this study, we describe the molecular basis for alteration of HSP70 gene expression by this class of antineoplastic compounds and provide evidence that isocyanate-induced damage causes activation of heat shock transcription factor (HSF) and a subset of genes regulated by this transcription factor.
MATERIALS AND METHODS
HeLa and HT-29 cells were maintained in Dulbecco's modification of Eagle's medium (DMEM) containing 10% bovine calf serum. Cells in middle to late exponential growth were treated with drugs as described (10). 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; B3ristol-Meyers), 1-(2-chloroethyl)-3-cyclohexyl-l-nitrosourea [CCNU; National Cancer Institute (NCI)], 1-(2-chloroethyl)-3-(methylcyclohexyl)-1-nitrosoutea (Me-CCNU; NCI), and 1,3-bis(trans-4-hydroxycyclohexyl)-1-nitrosourea (BHCNU; NCI) were dissolved in absolute ethanol, and ethyl, chloroethyl, and cyclohexyl isocyanate (Sigma) were dissolved in anhydrous dimethyl sulfoxide. All drugs were prepared at lOOx concentration immediately before use. Cells were washed with phosphatebuffered saline (PBS) after drug treatment and pulse-labeled with [3H]leucine (10 tkCi/ml; 1 Ci = 37 GBq) in leucine-free medium for 1 hr at 37°C. Equal amounts of trichloroacetic acid-precipitable radioactivity were analyzed by twodimensional (2D) gel electrophoresis (11) .
Cytoplasmic RNA was isolated from treated cells by lysis in a buffer containing 100 mM NaCI, 10 mM Tris-HCl (pH 8), 2 mM EDTA, 1% Nonidet P-40, 0.5% sodium deoxycholate, and 1% 2-mercaptoethanol. S1 nuclease assays were performed using a fragment of the human HSP70 gene that was 5' end-labeled at the Nco . site and that protects a 514-nucleotide transcript (12, 13) . For in vitro run-on transcription assays, nuclei were isolated from equal numbers of cells harvested at various times after treatment and the reactions were performed as described (14) . Gel mobility shift assays were performed with whole cell extracts prepared from treated HeLa cells using 10 ,g of extract and a 32P-labeled Proc. Nati. Acad. Sci. USA 88 (1991) heat shock element (32P-HSE) oligonucleotide containing four inverted HSE sequences (5'-CTAGAAGCTTCTA-GAAGCTTCTAG-3') (15, 16) . HeLa cells were transiently transfected with HSP70 promoter construct vectors as described (12) . The transfected cells were harvested either after treatment with BCNU or vehicle, as described, or after heat shock (420C for 1 hr). Cytoplasmic RNA was isolated and analyzed by S1 nuclease protection assays for HSP-CAT mRNA (CAT = chloramphenicol acetyltransferase; ref. 12) and endogenous HSP70 mRNA. For genomic footprinting analysis, -2 x 107 control or cycloheximide-pretreated HeLa cells were treated with 300 ,AM BCNU, as described.
As a positive control, an equivalent number of cells was subjected to heat shock at 420C for 30 min and processed concurrently. Immediately following treatment, cells isolated by mild trypsinization were resuspended in DMEM at 20'C, and genomic DNA was isolated following a 5-min treatment with 0.2% dimethyl sulfate (17) . The isolated, methylated DNA was then used for ligation-mediated PCR genomic footprinting (17, 18) .
RESULTS
Selective Activation of HSP70 and HSP90 by Nitrosoureas. We examined the effects of BCNU on the pattern of gene expression in cultured human tumor cells by analyzing the pattern of protein synthesis by 2D gel electrophoresis. Examination of proteins synthesized after a 1-hr treatment with 300 ,uM BCNU revealed a significant induction of HSP70 synthesis and slight induction of HSP90, the constitutively expressed p72, and the glucose-regulated protein GRP78 (Fig. 1) . Surprisingly, BCNU had little effect on the synthesis of other cellular proteins (Fig. 1) .
To establish whether BCNU affected gene expression at the transcriptional level we used in vitro nuclear run-on assays to assess the transcription rates of selected genes, including HSP90, HSP70, HSP60, and HSP27 stress genes and the c-fos, c-myc, and ,3-actin genes (Fig. 2) . Within 1-2 hr following BCNU treatment, transcription of the HSP70 gene increased 20-fold and returned to near basal levels by 6 hr. HSP70 mRNA levels increased with slightly delayed kinetics (Fig. 2C) . Similar patterns but a lower level (=10-fold) of transcriptional induction were observed for the HSP90 gene. In contrast, BCNU treatment had less than a 2-to 3-fold effect on the transcription of HSP60 and HSP27 genes or on the HSP70-related genes GRP78 and p72.
Carbamoylation via the Isocyanate Moiety Is the Inducer of Stress Protein Expression. The CENUs such as BCNU,
CCNU, and Me-CCNU produce a plethora of covalent modifications to intracellular constituents. Since induction of the stress response has been linked to protein damage (19, 20) , we examined whether the signal for CENU induction of HSP70 was due to isocyanate-mediated protein modification. Cells were treated with equimolar doses of these CENUs and with BHCNU, which retains high carbamoylating activity and no alkylating or crosslinking activity. Maximal levels of HSP70 mRNA were reached at 3-5 hr after a 1-hr treatment with each of these drugs. Shown in Fig. 3A is the S1 nuclease analysis of HSP70 mRNA levels 4 hr after treatment. Treatment with BCNU, CCNU, Me-CCNU, or BHCNU induced high levels of HSP70 mRNA. To obtain support for the hypothesis that the isocyanate moiety generated by the aqueous decomposition of these compounds was responsible for activation of the stress response, cells were treated with chloroethyl or cyclohexyl isocyanate, the carbamoylating moieties generated from BCNU or CCNU, respectively, or with ethyl isocyanate. Cytoplasmic RNA was isolated from cells at 4 hr after a 1-hr treatment and analyzed by S1 nuclease protection. As shown in Fig. 3 , treatment with the isocyanates induced HSP70 mRNA to levels similar to that obtained with the parental drugs. Nitrosourea Activation of HSP7O Transcription Is HSE Mediated. To identify sequences in the HSP70 promoter required for BCNU mediated-transcriptional activation, HeLa cells were transiently transfected with a human HSP70-CAT construct (LSNWT) that contains HSP70 promoter sequences (-188 to +150) fused to the CAT gene (12) . The transfected cells were subjected to heat shock or BCNU, and relative endogenous HSP70 and CAT mRNA levels were measured by S1 nuclease analysis. HSP-CAT mRNA and endogenous HSP70 mRNA were induced by BCNU (Fig.  4A) . A more detailed localization of the BCNU-responsive cis elements in the HSP70 promoter was obtained using a promoter with a mutation in the HSE and a construct retaining basal promoter sequences (-74 to + 1). The results of these studies (data not shown) indicated that an intact HSE was necessary and that the region from -74 to +1 was insufficient for BCNU induction.
A second approach to directly identify the cis-acting element(s) in the HSP70 promoter that responded to BCNU treatment used the in vivo genomic footprinting method. We have previously used the ligation-mediated PCR genomic footprinting method to identify factors bound in vivo to the HSP70 promoter and to demonstrate the inducible binding of HSF with specific guanine residues in the HSE (18) . guanine at position -95 of the noncoding strand and protections of the guanine residues at -% and -97 (Fig. 4B) (28) . Therefore, it will be of interest to ask whether the activation and expression of the 70-kDa and 90-kDa stress genes have protective value against BCNU-induced damage, in a manner analogous to the acquisition of thermotolerence. This also has particular relevance to the ever-growing need for use of combined modalities needed for successful chemotherapy. effect on the endoplasmic reticulum-associated cotranslational apparatus.
The observation that nitrosoureas selectively activate a subset of heat shock genes has interesting implications for the role of stress proteins in disease. Stress proteins have been recently shown to have a fundamental role in biological reactions involving protein folding, transport, and assembly (25) . Studies on thermotolerence have indicated that the increased or induced synthesis of certain stress proteins has
